Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore

• Published in: Journal of clinical pathology Vol. 75; no. 6; pp. 383 - 389
• Main Authors: Núñez-Torrón, Claudia, Ferrer-Gómez, Ana, Moreno Moreno, Esther, Pérez-Mies, Belen, Villarrubia, Jesús, Chamorro, Sandra, López-Jiménez, Javier, Palacios, J, Piris-Villaespesa, Miguel, García-Cosío, Mónica
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd and Association of Clinical Pathologists 01.06.2022; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Autopsies; bone; Bone marrow; COVID-19; Cytokine storm; Fever; Hyperplasia; Infections; Laboratories; Lymphatic system; Original Research; Patients; Severe acute respiratory syndrome coronavirus 2; Viral infections; Viruses; COVID-19; bone; bone marrow
• ISSN: 0021-9746; 1472-4146
• DOI: 10.1136/jclinpath-2020-207337

BackgroundSecondary haemophagocytic lymphohistiocytosis (sHLH) is characterised by a hyper activation of immune system that leads to multiorgan failure. It is suggested that excessive immune response in patients with COVID-19 could mimic this syndrome. Some COVID-19 autopsy studies have revealed the presence of haemophagocytosis images in bone marrow, raising the possibility, along with HScore parameters, of sHLH.AimOur objective is to ascertain the existence of sHLH in some patients with severe COVID-19.MethodsWe report the autopsy histological findings of 16 patients with COVID-19, focusing on the presence of haemophagocytosis in bone marrow, obtained from rib squeeze and integrating these findings with HScore parameters. CD68 immunohistochemical stains were used to highlight histiocytes and haemophagocytic cells. Clinical evolution and laboratory parameters of patients were collected from electronic clinical records.ResultsEleven patients (68.7%) displayed moderate histiocytic hyperplasia with haemophagocytosis (HHH) in bone marrow, three patients (18.7%) displayed severe HHH and the remainder were mild. All HScore parameters were collected in 10 patients (62.5%). Among the patients in which all parameters were evaluable, eight patients (80%) had an HScore >169. sHLH was not clinically suspected in any case.ConclusionsOur results support the recommendation of some authors to use the HScore in patients with severe COVID-19 in order to identify those who could benefit from immunosuppressive therapies. The presence of haemophagocytosis in bone marrow tissue, despite not being a specific finding, has proved to be a very useful tool in our study to identify these patients.